Mississippi Oncology Society

Mississippi Oncology Society We are an association that supports physicians and the entire medical team involved in the treatment

05/01/2026

FDA approves vepdegestrant for ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer

Wishing all Mississippi physicians especially those treating patients for cancer, a very Happy National Doctors’ Day.  T...
03/30/2026

Wishing all Mississippi physicians especially those treating patients for cancer, a very Happy National Doctors’ Day. Thank you for the dedication and desire to serve your patients and for advocating on their behalf to protect access to needed and necessary treatment options.

03/25/2026

FDA approves relacorilant with nab-paclitaxel for platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer

03/23/2026

FDA approved approved nivolumab (Opdivo, Bristol Myers Squibb Company) with doxorubicin, vinblastine, and dacarbazine (AVD) for cHL.

03/05/2026

On March 5, 2026, the Food and Drug Administration approved teclistamab (Tecvayli, Janssen Biotech, Inc.) in combination with daratumumab hyaluronidase-fihj for

02/26/2026

FDA granted accelerated approval to zongertinib, a kinase inhibitor, for an expanded indication for adults with certain lung cancers.

02/24/2026

FDA grants traditional approval to encorafenib for metastatic colorectal cancer with a BRAF V600E mutation

02/20/2026

FDA approves acalabrutinib with venetoclax for chronic lymphocytic leukemia or small lymphocytic lymphoma

02/10/2026

Full prescribing information for Keytruda and Keytruda Qlex will be posted on Drugs@FDA.

Address

574 E Ritchie Highway #271
Severna Park, MD
21146

Alerts

Be the first to know and let us send you an email when Mississippi Oncology Society posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Category